noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

Company News

Pharmaceuticals and Biotechnology

Lineage Cell Therapeutics Inc.

11/13/2026 | Press release | Distributed by Public on 11/13/2026 00:47

Lineage Announces Acquisition of NeuroAirmid Therapeutics and Clinical Stage Program for the Treatment of Huntington’s Disease

Read this content

Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Lineage Cell Therapeutics Inc. published this content on November 13, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 13, 2026 at 06:47 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]